A carregar...
Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
The standard regimen for the treatment of newly diagnosed primary CNS lymphoma (PCNSL) remains regimens that contain high-dose methotrexate (MTX). While these regimens can provide control for some patients, there is a dearth of options for the treatment of patients with PCNSL who cannot tolerate MTX...
Na minha lista:
| Publicado no: | CNS Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163401/ https://ncbi.nlm.nih.gov/pubmed/32141313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns-2019-0022 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|